QuidelOrtho (QDEL) To Report Earnings Tomorrow: Here Is What To Expect
QuidelOrtho (QDEL) will report earnings Thursday after the bell. The company missed last quarter’s revenue expectations, with revenue of $619.8M, down 10.5% YoY, and also missed EPS guidance and EPS estimates. For this quarter, analysts expect revenue flat YoY. QDEL is down 2.4% over the past month versus an average peer gain; average analyst price target is $21.33 vs $17.58.
How this was made
The 30-second read
Why it matters
The main tradable element is the earnings catalyst and the market’s baseline expectations, which can drive volatility and implied move pricing into the report.
Market read
A scheduled earnings event for QDEL with a cautious setup from prior-quarter misses and a peer read-across.
What to watch
The article does not provide segment mix, guidance details, or any new management commentary, so traders should focus on the actual earnings release for margin, cash flow, and updated EPS/guidance rather than the setup alone.
Background
The piece frames QDEL’s upcoming earnings against last quarter’s revenue decline and EPS misses, and notes consensus expectations for flat YoY revenue.
Ticker impact
QuidelOrtho (QDEL) is scheduled to report earnings this Thursday after the bell, with prior-quarter revenue and EPS misses highlighted.
Likely elevated volatility into the after-hours earnings release, with direction dependent on whether revenue stabilizes and EPS guidance improves versus the prior miss.
The newest concrete facts are the earnings timing and the recap of last quarter’s misses plus consensus expectations for flat YoY revenue; there is no new company-specific disclosure beyond the calendar and prior results.
Market effects
Peer results in healthcare equipment and supplies (GE HealthCare, Baxter) are cited as a read-across, potentially shaping expectations for diagnostic demand and margins.
No explicit regional impact described.
No explicit global impact described.
Counterpoint
If QDEL’s revenue is expected to be flat YoY and analysts have reconfirmed estimates, the stock may already be positioned for a “not-worse” quarter, reducing downside risk versus the prior miss narrative.
Key entities
- companyQuidelOrtho
NASDAQ-listed diagnostics company reporting earnings after the bell this Thursday.
- companyGE HealthCare
Peer cited as having delivered YoY revenue growth and a post-results stock rise.
- companyBaxter
Peer cited as having topped revenue expectations and risen after results.
